EFFICACY OF ULTRASOUNDGUIDED DOUBLE LUMEN CENTRAL VENOUS CATHETER INSERTION IN MINIMIZING MECHANICAL COMPLICATIONS AND BLOODSTREAM INFECTIONS AN EMPIRICAL EVIDENCE OF PAKISTAN

http://dx.doi.org/10.31703/gdddr.2023(VIII-II).09      10.31703/gdddr.2023(VIII-II).09      Published : Jun 2
Authored by : Khalid Hussain , Attiq Ur Rehman Khan , Salman Athar Qureshi , Ali Umair Tariq , MariaTariq , Bilal Ahmed

09 Pages : 69-73

References

  • Amsterdam, J. D., & Shults, J. (2009). Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? Journal of Affective Disorders, 115(1-2), 234–240. https://doi.org/10.1016/j.jad.2008.07.007
  • Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009). Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder. Neuropsychobiology, 59(4), 227–233. https://doi.org/10.1159/000226611
  • Buchborn, T., Lyons, T., & Knöpfel, T. (2018). Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.00017
  • Darmani, N. A., & Gerdes, C. F. (1995). Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacology Biochemistry and Behavior, 50(4), 545–550. https://doi.org/10.1016/0091-3057(94)00340-8
  • Goto, S., Terao, T., Tomita, M., & Uchimura, N. (2012). Aripiprazole may be free from tachyphylaxis: Preliminary findings. Psychiatry and Clinical Neurosciences, 66(2), 160–162. https://doi.org/10.1111/j.1440-1819.2011.02301.x
  • Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2019). Tachyphylaxis in major depressive disorder: A review of the current state of research. Journal of Affective Disorders, 245, 488–497. https://doi.org/10.1016/j.jad.2018.10.357
  • Katz, G. (2011). Tachyphylaxis/ tolerance to antidepressive medications: a review. The Israel Journal of Psychiatry and Related Sciences, 48(2), 129–135. https://pubmed.ncbi.nlm.nih.gov/22120449/
  • Lieb, J., & Balter, A. (1984). Antidepressant tachyphylaxis . Medical Hypotheses, 15(3), 279–291. https://doi.org/10.1016/0306-9877(84)90018-5
  • Pietrzykowski, A. Z., & Treistman, S. N. (2008). The Molecular Basis of Tolerance. Alcohol Research & Health, 31(4), 298–309. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860466/
  • Rothschild, A. J. (2008). The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity . Comprehensive Psychiatry, 49(5), 508–513. https://doi.org/10.1016/j.comppsych.2008.03.002
  • Skaff, R. (2019). Tachyphylaxis and desensitization depression . CNS Spectrums, 1–2. https://doi.org/10.1017/s1092852919001445
  • Sjöstedt, P., Enander, J., & Isung, J. (2021). Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.682868
  • Svensson, C. K. (2022). Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance. Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.121.000978
  • Targum, S. D. (2014). Identification and treatment of antidepressant tachyphylaxis. Innovations in Clinical Neuroscience, 11(3-4), 24–28. https://pubmed.ncbi.nlm.nih.gov/24800130/
  • Uchida, H., & Mamo, D. C. (2009). Dosing of antipsychotics in schizophrenia across the life-spectrum. Progress in Neuro- Psychopharmacology & Biological Psychiatry, 33(6), 917–920. https://doi.org/10.1016/j.pnpbp.2009.04.023
  • Amsterdam, J. D., & Shults, J. (2009). Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? Journal of Affective Disorders, 115(1-2), 234–240. https://doi.org/10.1016/j.jad.2008.07.007
  • Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009). Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder. Neuropsychobiology, 59(4), 227–233. https://doi.org/10.1159/000226611
  • Buchborn, T., Lyons, T., & Knöpfel, T. (2018). Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.00017
  • Darmani, N. A., & Gerdes, C. F. (1995). Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacology Biochemistry and Behavior, 50(4), 545–550. https://doi.org/10.1016/0091-3057(94)00340-8
  • Goto, S., Terao, T., Tomita, M., & Uchimura, N. (2012). Aripiprazole may be free from tachyphylaxis: Preliminary findings. Psychiatry and Clinical Neurosciences, 66(2), 160–162. https://doi.org/10.1111/j.1440-1819.2011.02301.x
  • Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2019). Tachyphylaxis in major depressive disorder: A review of the current state of research. Journal of Affective Disorders, 245, 488–497. https://doi.org/10.1016/j.jad.2018.10.357
  • Katz, G. (2011). Tachyphylaxis/ tolerance to antidepressive medications: a review. The Israel Journal of Psychiatry and Related Sciences, 48(2), 129–135. https://pubmed.ncbi.nlm.nih.gov/22120449/
  • Lieb, J., & Balter, A. (1984). Antidepressant tachyphylaxis . Medical Hypotheses, 15(3), 279–291. https://doi.org/10.1016/0306-9877(84)90018-5
  • Pietrzykowski, A. Z., & Treistman, S. N. (2008). The Molecular Basis of Tolerance. Alcohol Research & Health, 31(4), 298–309. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860466/
  • Rothschild, A. J. (2008). The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity . Comprehensive Psychiatry, 49(5), 508–513. https://doi.org/10.1016/j.comppsych.2008.03.002
  • Skaff, R. (2019). Tachyphylaxis and desensitization depression . CNS Spectrums, 1–2. https://doi.org/10.1017/s1092852919001445
  • Sjöstedt, P., Enander, J., & Isung, J. (2021). Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.682868
  • Svensson, C. K. (2022). Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance. Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.121.000978
  • Targum, S. D. (2014). Identification and treatment of antidepressant tachyphylaxis. Innovations in Clinical Neuroscience, 11(3-4), 24–28. https://pubmed.ncbi.nlm.nih.gov/24800130/
  • Uchida, H., & Mamo, D. C. (2009). Dosing of antipsychotics in schizophrenia across the life-spectrum. Progress in Neuro- Psychopharmacology & Biological Psychiatry, 33(6), 917–920. https://doi.org/10.1016/j.pnpbp.2009.04.023

Cite this article

    APA : Hussain, K., Khan, A. U. R., & Qureshi, S. A. (2023). Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan. Global Drug Design & Development Review, VIII(II), 69-73. https://doi.org/10.31703/gdddr.2023(VIII-II).09
    CHICAGO : Hussain, Khalid, Attiq Ur Rehman Khan, and Salman Athar Qureshi. 2023. "Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan." Global Drug Design & Development Review, VIII (II): 69-73 doi: 10.31703/gdddr.2023(VIII-II).09
    HARVARD : HUSSAIN, K., KHAN, A. U. R. & QURESHI, S. A. 2023. Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan. Global Drug Design & Development Review, VIII, 69-73.
    MHRA : Hussain, Khalid, Attiq Ur Rehman Khan, and Salman Athar Qureshi. 2023. "Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan." Global Drug Design & Development Review, VIII: 69-73
    MLA : Hussain, Khalid, Attiq Ur Rehman Khan, and Salman Athar Qureshi. "Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan." Global Drug Design & Development Review, VIII.II (2023): 69-73 Print.
    OXFORD : Hussain, Khalid, Khan, Attiq Ur Rehman, and Qureshi, Salman Athar (2023), "Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan", Global Drug Design & Development Review, VIII (II), 69-73
    TURABIAN : Hussain, Khalid, Attiq Ur Rehman Khan, and Salman Athar Qureshi. "Efficacy of Ultrasound‐Guided Double Lumen Central Venous Catheter Insertion in Minimizing Mechanical Complications and Bloodstream Infections: An Empirical Evidence of Pakistan." Global Drug Design & Development Review VIII, no. II (2023): 69-73. https://doi.org/10.31703/gdddr.2023(VIII-II).09